Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Rapid Emergence of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Korea

  • Ae Kyung Park (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • Il-Hwan Kim (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • Chae Young Lee (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • Jeong-Ah Kim (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • Hyeokjin Lee (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • Heui Man Kim (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • Nam-Joo Lee (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • SangHee Woo (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • Jaehee Lee (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • JeeEun Rhee (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • Cheon-Kwon Yoo (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA)) ;
  • Eun-Jin Kim (Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA))
  • Received : 2022.05.12
  • Accepted : 2022.09.11
  • Published : 2023.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

Acknowledgement

We acknowledge both the originating and submitting laboratories who have deposited and shared genome data from the GISAID EpiCoV database (https://www.gisaid.org/).

References

  1. WHO. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. https://www.who.int/news/item/26-11-2021-classification-ofomicron-(B.1.1.529)-sars-cov-2-variant-of-concern (Updated on Nov 2021).
  2. Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol 2021;19:409-24. https://doi.org/10.1038/s41579-021-00573-0
  3. Alenquer M, Ferreira F, Lousa D, Valério M, Medina-Lopes M, Bergman ML, et al. Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies. PLoS Pathog 2021;17:e1009772. https://doi.org/10.1371/journal.ppat.1009772
  4. Shu Y and McCauley J. GISAID: Global initiative on sharing all influenza data – from vision to reality. Euro Surveill 2017;22:30494. https://doi.org/10.2807/1560-7917.ES.2017.22.13.30494
  5. Park AK, Kim IH, Kim J, Kim JM, Kim HM, Lee CY, et al. Genomic surveillance of SARS-CoV-2: distribution of clades in the Republic of Korea in 2020. Osong Public Health Res Perspect 2021;12:37-43. https://doi.org/10.24171/j.phrp.2021.12.1.06
  6. Park AK, Kim IH, Man Kim H, Lee H, Lee NJ, Kim JA, et al. SARS-CoV-2 B.1.619 and B.1.620 lineages, South Korea, 2021. Emerg Infect Dis 2022;28:415-9. https://doi.org/10.3201/eid2802.211653
  7. Rambaut A, Holmes EC, Hill V, O'Toole Á, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology. Nat Microbiol 2020;5:1403-7. https://doi.org/10.1038/s41564-020-0770-5
  8. Kim EY, Choe YJ, Park H, Jeong H, Chung JH, Yu J, et al. Community transmission of SARS-CoV-2 Omicron variant, South Korea, 2021. Emerg Infect Dis 2022;28:898-900. https://doi.org/10.3201/eid2804.220006
  9. Liu L, Iketani S, Guo Y, Chan JF, Wang M, Liu L, et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 2022; 602:676-81. https://doi.org/10.1038/s41586-021-04388-0
  10. Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 2022; 602:657-63. https://doi.org/10.1038/s41586-021-04385-3